ProCE Banner Activity

The Psychopharmacology of Psychedelics


Downloadable slideset from the 9th Annual Psychopharmacology Update session on current trends in using psychedelics among patients with mood disorders, substance abuse disorders, and more.

Released: November 29, 2023



Michael Alpert

Michael Alpert, MD

Sub-investigator, Educator, Psychiatrist
MAPS Public Benefit Corporation
Department of Psychiatry
Beth Israel Deaconess Medical Center – Harvard Medical School
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


Supported by educational grants from AbbVie Inc.; Intra-Cellular Therapies, Inc.; Neurocrine Biosciences, Inc; and an independent educational grant from the Opioid Analgesic REMS Program Companies.

Please see this link for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the FDA.

AbbVie Inc.

Intra-Cellular Therapies, Inc.

Neurocrine Biosciences, Inc.

Opioid Analgesic REMS Program Companies